Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Updated EMPA-REG data show Jardiance also protects kidney

Boehringer Ingelheim and Lilly’s drug is the first to show positive impact on kidney damage

- PMLiVE

Developing Medical Education That Advances Patient Outcomes

As pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in...

Lucid Group Communications Limited

- PMLiVE

AZ’s Gabriel Baertschi joins Grünenthal as CEO

He also becomes chairman of the corporate executive board

- PMLiVE

Sue Neilen moves to Virgo Health from Langland

She becomes head of communications

Biosimilars – the Brexit of the pharmaceutical industry?

In this article, Senior Consultant Jenna Earl explains what factors influence the uptake of biosimilars in the UK, comparing them to the same principles that help us navigate the complexities...

Blue Latitude Health

- PMLiVE

Victoza cuts cardiovascular risk in landmark study

Novo Nordisk’s diabetes therapy outcomes ‘beyond expectations’

- PMLiVE

Teva suspends migraine patch on burn reports

FDA issues safety alert and instigates investigation into Zecuity

- PMLiVE

miRagen Therapeutics bolsters senior leadership team

Adam Levy and Christopher Mori take on new roles

- PMLiVE

Red Door Unlimited appoints head of social

Antia Buhigas joins the agency’s leadership team

- PMLiVE

Technology: the missing link in true patient engagement?

Approximately 50% of patients do not take their medication as prescribed. This comes at a huge financial cost, and results in suboptimal patient outcomes. There is a wealth of research...

Merck licences MS brain training programme

Strikes deal with HAPPYneuron to bolster its MSdialog platform for Rebif

- PMLiVE

Novo creates online diabetes management resource

Aims to educate UK patients and the public on the signs and impact of hypos

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links